Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07105826 · ClinicalTrials.gov registry record · NA
Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men
A NA study of Olipop and Poppi, sponsored by Texas Christian University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07105826: Recruiting NA study of Olipop and Poppi, sponsored by Texas Christian University.
NCT07105826 is a NA study of Olipop and Poppi that is actively recruiting participants, run by Texas Christian University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07105826, a NA study of Olipop and Poppi, is actively recruiting participants, sponsored by Texas Christian University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to study healthy men aged 18-40 to explore how different beverages affect hunger, blood sugar, insulin, and a hormone called GLP-1, which helps regulate appetite and blood sugar. The tested beverages include two prebiotic sodas (Olipop and Poppi), Diet Coke, and Coca-Cola Classic. What's the study about? It aims to understand how these drinks influence how full participants feel and how the body handles sugar and hormones compared to each other. This could help us learn more about how prebiotic drinks, which may support gut health, compare to regular sugary or diet sodas. What will participants do? Participants will visit our lab at TCU (Rickel Building, rooms 256/259) four times over four weeks, with each visit lasting about 2-2.5 hours. Participants will need to fast for 8-12 hours before each visit. Here's what happens: * First visit involves participants' consent, measurement of height and weight, and performing a finger-stick test to check blood sugar and HbA1C. Participants will also fill out questionnaires about health, diet, and beverage preferences. * Visits 2-4: In visit 2, a DEXA scan will be performed to assess body composition. In visits 2-4, participants will drink one of the four beverages (in a random order, served in an unlabeled black container to prevent drink identification). Other variables measured at these time points include blood pressure, fasting glucose, insulin, and GLP-1. Participants will also complete questionnaires about hunger and how the drink tastes. Each visit is spaced out by a week, and the total time commitment is about 10.5 hours. The study is expected to complete participant recruitment by December 10, 2025. Who can join? Ten healthy men aged 18-40 who don't have diabetes, heart disease, kidney or liver issues, or other specific health conditions. Participants shouldn't smoke, vape, or have certain dietary habits like intermittent fasting. Participants will be screened to confirm eligibility. What are th
Primary Outcome
The AUC of plasma glucose concentrations will be compared between the four conditions.
Conditions Studied
Interventions
- OTHER Prebiotic Soda 1
- OTHER Prebiotic Soda 2
- OTHER Diet Soda
- OTHER Regular Coke
Study Locations (1)
Texas
- Texas Christian University - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2025-12-10 |
| Phase | NA |
What NCT07105826 shows while recruiting
NCT07105826 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Olipop appearing as the primary indexed condition, and to 4 interventions - of which Prebiotic Soda 1 is the first listed.
NCT07105826 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07105826 about?
NCT07105826 is a clinical study titled "Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men". The study aims to study healthy men aged 18-40 to explore how different beverages affect hunger, blood sugar, insulin, and a hormone called GLP-1, which helps regulate appetite and blood sugar. The tested beverages include two prebiotic sodas (Olipop and Poppi), Diet Coke, and Coca-Cola Classic. Wh...
What is the current status of trial NCT07105826?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-08-04. Estimated completion is 2025-12-10.
What conditions does trial NCT07105826 study?
This clinical trial studies the following conditions: Olipop, Poppi, Coca Cola - Classic, Diet Coke.
What interventions are being tested in trial NCT07105826?
The interventions under investigation include: Prebiotic Soda 1 (OTHER), Prebiotic Soda 2 (OTHER), Diet Soda (OTHER), Regular Coke (OTHER).
Who is sponsoring clinical trial NCT07105826?
This trial is sponsored by Texas Christian University, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07105826 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07105826's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI